Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/03/2012US8211945 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
07/03/2012US8211944 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function
07/03/2012US8211943 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
07/03/2012US8211942 Compositions and methods for dry eye syndrome
07/03/2012US8211941 Antagonists of the transient receptor potential vanilloid 1 and uses thereof
07/03/2012US8211940 Oxaliplatin active substance with a very low content of oxalic acid
07/03/2012US8211939 Isosorbide nitrates
07/03/2012US8211938 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
07/03/2012US8211937 7-pyrollyl 9-aminoacyl tetracycline compounds and methods of use thereof
07/03/2012US8211936 Co-crystals of pyrrolidinones
07/03/2012US8211935 Heterocyclic derivatives for modulation of calcium channels
07/03/2012US8211934 Small molecule inhibition of PDZ-domain interaction
07/03/2012US8211933 3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same
07/03/2012US8211932 Organic compounds and their uses
07/03/2012US8211930 Phenyl and benzodioxinyl substituted indazoles derivatives
07/03/2012US8211929 N2-{[3-(1-methylethyl)isoxazol-5-yl]methyl}-N4-[5-(1-methylethyl)-1H-pyrazol-3-yl]-6-[(1-methylpiperidin-3-yl)oxy]pyrimidine-2,4-diamine; IGF1R modulators; Abl mutant inhibitors; antiproliferative agents; to modulate cellular activities like differentiation, programmed cell death, migration, chemoinvas
07/03/2012US8211928 Hepatitis C virus inhibitors
07/03/2012US8211927 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators
07/03/2012US8211926 Bicyclic pyrazolo-heterocycles
07/03/2012US8211925 Benzamide glucokinase activators
07/03/2012US8211924 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
07/03/2012US8211923 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
07/03/2012US8211922 1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211920 6-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
07/03/2012US8211919 Amide derivatives as rock inhibitors
07/03/2012US8211918 Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
07/03/2012US8211916 Central nervous system disorders; drug abuse; Parkinson's disease; antidepressants
07/03/2012US8211915 Biphenyl compounds useful as muscarinic receptor antagonists
07/03/2012US8211914 Inhibitors of diacylglycerol acyltransferase
07/03/2012US8211913 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes
07/03/2012US8211912 Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl tranferase inhibitor
07/03/2012US8211911 Compounds as kinase inhibitors
07/03/2012US8211910 Tri-, tetra-substituted-3-aminopyrrolidine derivative
07/03/2012US8211909 Treatment of antibiotic-resistant bacteria infection
07/03/2012US8211908 Heterocyclic compound or salt thereof and intermediate thereof
07/03/2012US8211907 Fused indane compound
07/03/2012US8211905 Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
07/03/2012US8211904 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
07/03/2012US8211903 Substituted pyrimido isoquinoline derivatives
07/03/2012US8211902 Quinazolinone derivatives useful as vanilloid antagonists
07/03/2012US8211901 Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
07/03/2012US8211900 DHFR enzyme inhibitors
07/03/2012US8211899 Artificial nucleic acid bases and their use in base pairing natural nucleic acid bases
07/03/2012US8211898 Substituted thieno[3,2-d]pyrimidines as HIV inhibitors
07/03/2012US8211897 Inhibitors of cathepsin B
07/03/2012US8211896 Aryl sulfonamides
07/03/2012US8211895 Capped pyrazinoylguanidine sodium channel blockers
07/03/2012US8211894 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
07/03/2012US8211893 Protein kinase C zeta inhibition to treat diabetic retinopathy
07/03/2012US8211892 Tetrahydroquinoxaline urea derivatives
07/03/2012US8211891 Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
07/03/2012US8211890 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
07/03/2012US8211889 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
07/03/2012US8211888 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
07/03/2012US8211887 Topical preparation and method for transdermal delivery and localization of therapeutic agents
07/03/2012US8211885 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
07/03/2012US8211884 2,2-Dimethyl-4-oxo-4-(4-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-[1,4]diazepan-1-yl)-butyric acid, hydrochloride; obesity, type II diabetes mellitus and metabolic syndrome
07/03/2012US8211883 Topical delivery of phthalocyanines
07/03/2012US8211882 Glutamate receptor modulators and therapeutic agents
07/03/2012US8211881 For detecting and measuring effects on biological membranes; cyclodextrins
07/03/2012US8211880 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
07/03/2012US8211879 Cationic steroid antimicrobial compositions and methods of use
07/03/2012US8211878 Method for reducing neuronal death in nervous system injuries resulting from amyotrophic lateral sclerosis
07/03/2012US8211877 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
07/03/2012US8211876 Compositions for treatment of inflammatory diseases
07/03/2012US8211875 Local treatment of neurofibromas
07/03/2012US8211874 Inhibition of thrombin generation
07/03/2012US8211873 Antiaging chirally-correct mitoprotectant amino acid and peptide complexes
07/03/2012US8211872 Method and composition for treatment of multiple sclerosis and related neurodegenerative conditions
07/03/2012US8211871 Topical skin barriers and methods of evaluation thereof
07/03/2012US8211870 Use of pharmaceutical compound in the treatment of wounds
07/03/2012US8211869 Methods for cancer therapy and stem cell modulation
07/03/2012US8211864 Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
07/03/2012US8211863 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
07/03/2012US8211862 Pharmaceutical compositions comprising crystal forms of 5-azacytidine
07/03/2012US8211860 Carbohydrate-lipid constructs and their use in preventing or treating viral infection
07/03/2012US8211859 α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
07/03/2012US8211854 Methods for inhibiting protein kinases
07/03/2012US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor
07/03/2012US8211613 prints, color filters, electronics, layer insulation films, wire covering films, optics, circuits, antireflection films, holograms and construction materials comprising a cured mixture of photosensitive resins and photoiniitiators having a naphthalimide structure
07/03/2012US8211483 Composition comprising starch or dietary fiber from gramineae plant for prevention and treatment of ischemic diseases and degenerative brain disease
07/03/2012US8211473 Stable formulations for lyophilizing therapeutic particles
07/03/2012US8211466 Mucosal bioadhesive slow release carrier for delivering active principles
07/03/2012US8211465 Immediate release and sustained release ibuprofen dosing regimen
07/03/2012US8211462 Transdermal therapeutic system (TTS); cement matrix contains a hot-meltable adhesive in which the active substance Rotigotine ((-)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl)amino]-1-napththol) is dispersed and dissolved; solvent-free
07/03/2012US8211460 Formulations, devices and methods for treating and preventing mucositis
07/03/2012US8211454 Paper product with disinfecting properties
07/03/2012US8211453 Antibacterial composition containing organic silver complexes, antibacterial treatment methods using the same and antibacterial formed article
07/03/2012US8211421 Mutant having uracil phosphoribosyl transferase activity
07/03/2012US8211418 Protein-based polymer tissue adhesives for medical use
07/03/2012US8211402 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
07/03/2012US8211401 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
07/03/2012US8211318 Biocides and apparatus
07/03/2012CA2694227C Compositions and methods for treating or controlling anterior-segment inflammation
07/03/2012CA2672839C Treatment of lung cancer with s-farnesylthiosalicylic acid and analogs thereof
07/03/2012CA2672452C Tannate salt of rasagiline
07/03/2012CA2671904C Intermediate duration neuromuscular blocking agents and antagonists thereof
07/03/2012CA2661960C Noninvasive measurements of chemical substances
07/03/2012CA2584757C Halogen substituted benzodiazepine derivatives
1 ... 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 ... 7860